KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $878.5 million.

  • Emergent BioSolutions' Total Liabilities fell 937.69% to $878.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $878.5 million, marking a year-over-year decrease of 937.69%. This contributed to the annual value of $906.9 million for FY2024, which is 2274.47% down from last year.
  • Emergent BioSolutions' Total Liabilities amounted to $878.5 million in Q3 2025, which was down 937.69% from $880.9 million recorded in Q2 2025.
  • Emergent BioSolutions' Total Liabilities' 5-year high stood at $1.8 billion during Q4 2022, with a 5-year trough of $873.4 million in Q1 2025.
  • Its 5-year average for Total Liabilities is $1.2 billion, with a median of $1.2 billion in 2022.
  • In the last 5 years, Emergent BioSolutions' Total Liabilities surged by 4498.38% in 2023 and then plummeted by 3476.99% in 2024.
  • Emergent BioSolutions' Total Liabilities (Quarter) stood at $1.3 billion in 2021, then surged by 32.12% to $1.8 billion in 2022, then tumbled by 34.0% to $1.2 billion in 2023, then decreased by 22.74% to $906.9 million in 2024, then decreased by 3.13% to $878.5 million in 2025.
  • Its Total Liabilities was $878.5 million in Q3 2025, compared to $880.9 million in Q2 2025 and $873.4 million in Q1 2025.